Hormonal Regulation of Acetyl-CoA Carboxylase Isoenzyme Gene Transcription
Tóm tắt
Từ khóa
Tài liệu tham khảo
1. Wakil SJ, Abu-Elheiga LA (2009) Fatty acid metabolism: target for metabolic syndrome. <I>J Lipid Res </I>50 (Suppl): S138-S143.
2. López-Casillas F, Ponce-Castañeda MV, Kim KH.Mao J, DeMayo FJ (1992) Acetyl-coenzyme A carboxylase mRNA metabolism in the rat liver. <I>Metabolism </I>41: 201-207.
9. Kim KW, Yamane H (2006) Expression, purification, and characterization of human acetyl-CoA carboxylase 2. <I>Protein Expr Purif </I>53: 16-23.
16. Denechaud PD, Bossard P, Lobaccaro JM, Millatt L, Staels B, Girard J, Postic C (2008) ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver. <I>J Clin Invest </I>118: 956-964.
19. Choi DH, Choi JH, Whang SK, Kim YS (1989) Regulation of acetyl CoA carboxylase mRNA in rat liver by high carbohydrate diet and insulin. <I>Yonsei Med J </I>30: 235-245.
22. Yanovski JA, Cutler GB Jr (1994) Glucocorticoid action and the clinical features of Cushing’s syndrome. <I>Endocrinol Metab Clin North Am </I>23: 487-509.
24. Mounier C, Posner BI (2006) Transcriptional regulation by insulin: from the receptor to the gene. <I>Can J Physiol Pharmacol </I>84: 713-724.
27. Wójcicka G, Jamroz-Wisniewska A, Horoszewicz K, Beitowski J (2007) Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism. <I>Postepy Hig Med Dosw </I>61: 736-759.
30. Postic C, Dentin R (2007) ChREBP, a transcriptional regulator of glucose and lipid metabolism. <I>Annu Rev Nutr </I>27: 179-192.
34. Iwasaki Y, Takayasu S, Nishiyama M, Tsugita M, Taguchi T, Asai M, Yoshida M, Kambayashi M, Hashimoto K (2008) Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11β-hydroxysteroid dehydrogenase type 1) gene. <I>Mol Cell Endocrinol </I>285: 10-18.
35. Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP (2009) The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. <I>J Clin Endocrinol Metab </I>94: 2692-2701.
36. Harwood HJ Jr (2005) Treating the metabolic syndrome: acetyl-CoA carboxylase inhibition. <I>Expert Opin Ther Targets </I>9: 267-281.